UPClytics
View all cases

UPC CFI 395/2023

Oct 30, 2023·EP3831282 · REMOTE MONITORING OF ANALYTE MEASUREMENTS

Case details
Status
Case Closed (Patent revoked)
Action
Infringement
Category
Main infringement action
Parties
Claimants
Representatives
Respondents
Representatives
Division
Paris LD
Technology
  • Electrical engineering
    Digital communication
  • Instruments
    Medical technology
Language
English
First decided
Feb 12, 2024
Last decision
Dec 11, 2024
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
Infringement foundMedian days to first decision
All UPC53% (62/117)124
Paris LDLockedLocked
Judge Camille LignièresLockedLocked
Judge Carine GilletLockedLocked
Judge Rute LopesLockedLocked
Judge Alain DumontLockedLocked

At the UPC: Dexcom Group (39 cases)·Abbott Group (67 cases)

This dispute contains 3 other proceedings

UPC CoA 840/2024·UPC CFI 625/2024·UPC APP 53731/2024

1 other defendants litigating the same or a related patent

CC 14065/2024

Start a free trial to see how each one ended.

More cases: Paris LD·2023

Decisions
  • 2024-12-11

    Summary: Decision on the merits from the Paris Local Division (UPC_CFI_395/2023) delivered on 11 December 2024 in DexCom's infringement action against Abbott entities concerning EP 3 831 282. The Court found the patent invalid in its entirety — neither as granted nor as amended by auxiliary requests 1, 2 or 3 — due to added subject-matter under Art. 138(1)(c) EPC. The infringement action was dismissed for lack of legal basis. DexCom was ordered to bear Abbott's costs, with the amount to be determined in separate proceedings.

    Show the legal issues (5)
    • Added matter (Art. 138(1)(c) EPC)
    • Auxiliary requests for patent amendment
    • Admissibility of new grounds for revocation in rejoinder (R. 9.2 RoP)
    • Claim interpretation (whole-content approach)
    • Inventive step (Art. 56 EPC)
  • 2024-11-25

    Summary: Procedural order from the Paris Local Division dated 25 November 2024 on DexCom's application (under R. 334(e) and R. 336 RoP) requesting the court to allow post-hearing submissions regarding a Munich Regional Court decision of 6 November 2024 on EP 2 939 158 (parent patent of EP 3 831 282 in suit). The court had closed the oral hearing on 30 October 2024. DexCom argued the Munich decision finding infringement by Abbott of the parent patent's claim 1 was relevant. Abbott argued the application was inadmissible. The order addresses admissibility of supplemental submissions after closure of hearing under Chapter 8 RoP case management provisions.

    Show the legal issues (3)
    • Post-hearing supplemental submissions under R. 334(e) and R. 336 RoP
    • Relevance of parallel national court decisions
    • Case management after closure of oral hearing
  • 2024-02-12

    Summary: Procedural order from the Paris Local Division granting an extension and alignment of deadlines for filing the Statement of Defence in an infringement action by DexCom against 14 Abbott group defendants. The parties had orally agreed on a filing date at a case management meeting, which the Judge-Rapporteur considered reasonable. The order also confirmed service completion details for each defendant.

    Show the legal issues (3)
    • Extension of time limits (R. 23 RoP)
    • Alignment of deadlines for multiple defendants
    • Service of Statement of Claim on multiple defendants
Document titleDatePublic
Case Closure Formal Check2025-09-02Not public
Withdrawal Order CoA2025-09-02Not public
Receipt2024-12-18Not public
Application pursuant to R. 115 RoP2024-12-17Not public
Headnote-and-Keywords2024-12-11Not public
Decision on the merits DEXCOM v ABBOTT 11 Dec 20242024-12-11Public
Outcome of the Order2024-11-28Not public
Confirmation of appointment2024-11-28Public
Receipt2024-11-28Not public
Application pursuant to R. 115 RoP2024-11-27Not public